nodes	percent_of_prediction	percent_of_DWPC	metapath
Nitroglycerin—ALDH2—Phase 1 - Functionalization of compounds—CYP27A1—osteoporosis	0.00294	0.0463	CbGpPWpGaD
Nitroglycerin—GUCY1A3—Myometrial Relaxation and Contraction Pathways—ACTG1—osteoporosis	0.00256	0.0404	CbGpPWpGaD
Nitroglycerin—ALDH2—Tryptophan metabolism—CYP19A1—osteoporosis	0.00236	0.0371	CbGpPWpGaD
Nitroglycerin—GUCY1B3—Hemostasis—WDR1—osteoporosis	0.00229	0.036	CbGpPWpGaD
Nitroglycerin—GUCY1A2—Hemostasis—WDR1—osteoporosis	0.00229	0.036	CbGpPWpGaD
Nitroglycerin—GUCY1A3—Hemostasis—WDR1—osteoporosis	0.00204	0.0321	CbGpPWpGaD
Nitroglycerin—GUCY1A2—Hemostasis—CAP1—osteoporosis	0.00181	0.0285	CbGpPWpGaD
Nitroglycerin—GUCY1B3—Hemostasis—CAP1—osteoporosis	0.00181	0.0285	CbGpPWpGaD
Nitroglycerin—GUCY1A3—Hemostasis—CAP1—osteoporosis	0.00161	0.0254	CbGpPWpGaD
Nitroglycerin—GUCY1A3—Myometrial Relaxation and Contraction Pathways—CALCA—osteoporosis	0.00159	0.0251	CbGpPWpGaD
Nitroglycerin—Infestation—Estradiol—osteoporosis	0.00159	0.0017	CcSEcCtD
Nitroglycerin—Infestation NOS—Estradiol—osteoporosis	0.00159	0.0017	CcSEcCtD
Nitroglycerin—Gastrointestinal disorder—Ibandronate—osteoporosis	0.00159	0.00169	CcSEcCtD
Nitroglycerin—Syncope—Pamidronate—osteoporosis	0.00158	0.00169	CcSEcCtD
Nitroglycerin—Unspecified disorder of skin and subcutaneous tissue—Risedronate—osteoporosis	0.00157	0.00168	CcSEcCtD
Nitroglycerin—Pruritus—Etidronic acid—osteoporosis	0.00157	0.00167	CcSEcCtD
Nitroglycerin—Gastrointestinal pain—Estropipate—osteoporosis	0.00157	0.00167	CcSEcCtD
Nitroglycerin—ALDH2—Biological oxidations—CYP27A1—osteoporosis	0.00156	0.0246	CbGpPWpGaD
Nitroglycerin—Mental disorder—Conjugated Estrogens—osteoporosis	0.00156	0.00167	CcSEcCtD
Nitroglycerin—Feeling abnormal—Alendronate—osteoporosis	0.00156	0.00166	CcSEcCtD
Nitroglycerin—Erythema—Conjugated Estrogens—osteoporosis	0.00155	0.00166	CcSEcCtD
Nitroglycerin—Loss of consciousness—Pamidronate—osteoporosis	0.00155	0.00166	CcSEcCtD
Nitroglycerin—ALDH2—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	0.00154	0.0243	CbGpPWpGaD
Nitroglycerin—Gastrointestinal pain—Alendronate—osteoporosis	0.00154	0.00165	CcSEcCtD
Nitroglycerin—Infection—Ethinyl Estradiol—osteoporosis	0.00154	0.00165	CcSEcCtD
Nitroglycerin—Nervous system disorder—Ethinyl Estradiol—osteoporosis	0.00152	0.00163	CcSEcCtD
Nitroglycerin—Urticaria—Estropipate—osteoporosis	0.00152	0.00163	CcSEcCtD
Nitroglycerin—Vision blurred—Zoledronate—osteoporosis	0.00152	0.00162	CcSEcCtD
Nitroglycerin—Gastrointestinal pain—Raloxifene—osteoporosis	0.00152	0.00162	CcSEcCtD
Nitroglycerin—Body temperature increased—Estropipate—osteoporosis	0.00151	0.00162	CcSEcCtD
Nitroglycerin—Abdominal pain—Estropipate—osteoporosis	0.00151	0.00162	CcSEcCtD
Nitroglycerin—Feeling abnormal—Ibandronate—osteoporosis	0.00151	0.00162	CcSEcCtD
Nitroglycerin—Skin disorder—Ethinyl Estradiol—osteoporosis	0.00151	0.00161	CcSEcCtD
Nitroglycerin—Infection—Risedronate—osteoporosis	0.0015	0.00161	CcSEcCtD
Nitroglycerin—Gastrointestinal pain—Ibandronate—osteoporosis	0.0015	0.0016	CcSEcCtD
Nitroglycerin—Urticaria—Alendronate—osteoporosis	0.0015	0.0016	CcSEcCtD
Nitroglycerin—Abdominal pain—Alendronate—osteoporosis	0.00149	0.00159	CcSEcCtD
Nitroglycerin—Body temperature increased—Alendronate—osteoporosis	0.00149	0.00159	CcSEcCtD
Nitroglycerin—Shock—Risedronate—osteoporosis	0.00149	0.00159	CcSEcCtD
Nitroglycerin—Nervous system disorder—Risedronate—osteoporosis	0.00149	0.00159	CcSEcCtD
Nitroglycerin—Agitation—Zoledronate—osteoporosis	0.00148	0.00158	CcSEcCtD
Nitroglycerin—Angioedema—Zoledronate—osteoporosis	0.00147	0.00157	CcSEcCtD
Nitroglycerin—Skin disorder—Risedronate—osteoporosis	0.00147	0.00157	CcSEcCtD
Nitroglycerin—Gastrointestinal pain—Calcitriol—osteoporosis	0.00147	0.00157	CcSEcCtD
Nitroglycerin—Abdominal pain—Raloxifene—osteoporosis	0.00147	0.00157	CcSEcCtD
Nitroglycerin—Body temperature increased—Raloxifene—osteoporosis	0.00147	0.00157	CcSEcCtD
Nitroglycerin—Vision blurred—Conjugated Estrogens—osteoporosis	0.00146	0.00156	CcSEcCtD
Nitroglycerin—Urticaria—Ibandronate—osteoporosis	0.00146	0.00156	CcSEcCtD
Nitroglycerin—Abdominal pain—Ibandronate—osteoporosis	0.00145	0.00155	CcSEcCtD
Nitroglycerin—Body temperature increased—Ibandronate—osteoporosis	0.00145	0.00155	CcSEcCtD
Nitroglycerin—Confusional state—Pamidronate—osteoporosis	0.00145	0.00155	CcSEcCtD
Nitroglycerin—Vertigo—Zoledronate—osteoporosis	0.00145	0.00155	CcSEcCtD
Nitroglycerin—Syncope—Zoledronate—osteoporosis	0.00144	0.00154	CcSEcCtD
Nitroglycerin—Anaphylactic shock—Pamidronate—osteoporosis	0.00144	0.00154	CcSEcCtD
Nitroglycerin—GUCY1B3—Hemostasis—MGLL—osteoporosis	0.00144	0.0226	CbGpPWpGaD
Nitroglycerin—GUCY1A2—Hemostasis—MGLL—osteoporosis	0.00144	0.0226	CbGpPWpGaD
Nitroglycerin—Infection—Pamidronate—osteoporosis	0.00143	0.00153	CcSEcCtD
Nitroglycerin—Rhinitis—Estradiol—osteoporosis	0.00143	0.00153	CcSEcCtD
Nitroglycerin—Urticaria—Calcitriol—osteoporosis	0.00143	0.00153	CcSEcCtD
Nitroglycerin—Palpitations—Zoledronate—osteoporosis	0.00142	0.00152	CcSEcCtD
Nitroglycerin—Abdominal pain—Calcitriol—osteoporosis	0.00142	0.00152	CcSEcCtD
Nitroglycerin—Body temperature increased—Calcitriol—osteoporosis	0.00142	0.00152	CcSEcCtD
Nitroglycerin—Angioedema—Conjugated Estrogens—osteoporosis	0.00142	0.00151	CcSEcCtD
Nitroglycerin—Shock—Pamidronate—osteoporosis	0.00142	0.00151	CcSEcCtD
Nitroglycerin—Loss of consciousness—Zoledronate—osteoporosis	0.00142	0.00151	CcSEcCtD
Nitroglycerin—Pharyngitis—Estradiol—osteoporosis	0.00142	0.00151	CcSEcCtD
Nitroglycerin—Hypersensitivity—Estropipate—osteoporosis	0.00141	0.00151	CcSEcCtD
Nitroglycerin—Nervous system disorder—Pamidronate—osteoporosis	0.00141	0.00151	CcSEcCtD
Nitroglycerin—Vomiting—Etidronic acid—osteoporosis	0.00141	0.0015	CcSEcCtD
Nitroglycerin—Oedema peripheral—Estradiol—osteoporosis	0.00141	0.0015	CcSEcCtD
Nitroglycerin—Tachycardia—Pamidronate—osteoporosis	0.0014	0.0015	CcSEcCtD
Nitroglycerin—Rash—Etidronic acid—osteoporosis	0.0014	0.00149	CcSEcCtD
Nitroglycerin—Dermatitis—Etidronic acid—osteoporosis	0.0014	0.00149	CcSEcCtD
Nitroglycerin—Vertigo—Conjugated Estrogens—osteoporosis	0.00139	0.00149	CcSEcCtD
Nitroglycerin—Hyperhidrosis—Pamidronate—osteoporosis	0.00139	0.00149	CcSEcCtD
Nitroglycerin—Syncope—Conjugated Estrogens—osteoporosis	0.00139	0.00149	CcSEcCtD
Nitroglycerin—Hypersensitivity—Alendronate—osteoporosis	0.00139	0.00148	CcSEcCtD
Nitroglycerin—Headache—Etidronic acid—osteoporosis	0.00139	0.00148	CcSEcCtD
Nitroglycerin—Asthenia—Estropipate—osteoporosis	0.00137	0.00147	CcSEcCtD
Nitroglycerin—Visual impairment—Estradiol—osteoporosis	0.00137	0.00147	CcSEcCtD
Nitroglycerin—Palpitations—Conjugated Estrogens—osteoporosis	0.00137	0.00146	CcSEcCtD
Nitroglycerin—Loss of consciousness—Conjugated Estrogens—osteoporosis	0.00136	0.00146	CcSEcCtD
Nitroglycerin—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—osteoporosis	0.00136	0.00145	CcSEcCtD
Nitroglycerin—Paraesthesia—Risedronate—osteoporosis	0.00136	0.00145	CcSEcCtD
Nitroglycerin—Pruritus—Estropipate—osteoporosis	0.00136	0.00145	CcSEcCtD
Nitroglycerin—Asthenia—Alendronate—osteoporosis	0.00135	0.00145	CcSEcCtD
Nitroglycerin—Hypersensitivity—Ibandronate—osteoporosis	0.00135	0.00145	CcSEcCtD
Nitroglycerin—Dyspnoea—Risedronate—osteoporosis	0.00135	0.00144	CcSEcCtD
Nitroglycerin—Hypotension—Pamidronate—osteoporosis	0.00135	0.00144	CcSEcCtD
Nitroglycerin—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.00134	0.00143	CcSEcCtD
Nitroglycerin—Pruritus—Alendronate—osteoporosis	0.00134	0.00143	CcSEcCtD
Nitroglycerin—Confusional state—Zoledronate—osteoporosis	0.00133	0.00142	CcSEcCtD
Nitroglycerin—Hypersensitivity—Calcitriol—osteoporosis	0.00133	0.00142	CcSEcCtD
Nitroglycerin—Flushing—Estradiol—osteoporosis	0.00132	0.00141	CcSEcCtD
Nitroglycerin—Cardiac disorder—Estradiol—osteoporosis	0.00132	0.00141	CcSEcCtD
Nitroglycerin—Asthenia—Ibandronate—osteoporosis	0.00132	0.00141	CcSEcCtD
Nitroglycerin—Nausea—Etidronic acid—osteoporosis	0.00132	0.0014	CcSEcCtD
Nitroglycerin—Anaphylactic shock—Zoledronate—osteoporosis	0.00131	0.0014	CcSEcCtD
Nitroglycerin—GUCY1B3—Hemostasis—PLEK—osteoporosis	0.00131	0.0207	CbGpPWpGaD
Nitroglycerin—GUCY1A2—Hemostasis—PLEK—osteoporosis	0.00131	0.0207	CbGpPWpGaD
Nitroglycerin—GUCY1A2—Hemostasis—ANXA2—osteoporosis	0.00131	0.0207	CbGpPWpGaD
Nitroglycerin—GUCY1B3—Hemostasis—ANXA2—osteoporosis	0.00131	0.0207	CbGpPWpGaD
Nitroglycerin—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.00131	0.0014	CcSEcCtD
Nitroglycerin—Gastrointestinal disorder—Risedronate—osteoporosis	0.00131	0.0014	CcSEcCtD
Nitroglycerin—Infection—Zoledronate—osteoporosis	0.00131	0.00139	CcSEcCtD
Nitroglycerin—Pruritus—Ibandronate—osteoporosis	0.0013	0.00139	CcSEcCtD
Nitroglycerin—Angiopathy—Estradiol—osteoporosis	0.00129	0.00138	CcSEcCtD
Nitroglycerin—Shock—Zoledronate—osteoporosis	0.00129	0.00138	CcSEcCtD
Nitroglycerin—Paraesthesia—Pamidronate—osteoporosis	0.00129	0.00138	CcSEcCtD
Nitroglycerin—Asthenia—Calcitriol—osteoporosis	0.00129	0.00138	CcSEcCtD
Nitroglycerin—Nervous system disorder—Zoledronate—osteoporosis	0.00129	0.00138	CcSEcCtD
Nitroglycerin—Immune system disorder—Estradiol—osteoporosis	0.00129	0.00138	CcSEcCtD
Nitroglycerin—Mediastinal disorder—Estradiol—osteoporosis	0.00129	0.00137	CcSEcCtD
Nitroglycerin—Dyspnoea—Pamidronate—osteoporosis	0.00128	0.00137	CcSEcCtD
Nitroglycerin—Tachycardia—Zoledronate—osteoporosis	0.00128	0.00137	CcSEcCtD
Nitroglycerin—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.00128	0.00137	CcSEcCtD
Nitroglycerin—Somnolence—Pamidronate—osteoporosis	0.00128	0.00137	CcSEcCtD
Nitroglycerin—GUCY1A3—Hemostasis—MGLL—osteoporosis	0.00128	0.0202	CbGpPWpGaD
Nitroglycerin—Skin disorder—Zoledronate—osteoporosis	0.00128	0.00136	CcSEcCtD
Nitroglycerin—Pruritus—Calcitriol—osteoporosis	0.00127	0.00136	CcSEcCtD
Nitroglycerin—Hyperhidrosis—Zoledronate—osteoporosis	0.00127	0.00136	CcSEcCtD
Nitroglycerin—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.00127	0.00136	CcSEcCtD
Nitroglycerin—Dizziness—Estropipate—osteoporosis	0.00127	0.00135	CcSEcCtD
Nitroglycerin—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.00127	0.00135	CcSEcCtD
Nitroglycerin—Infection—Conjugated Estrogens—osteoporosis	0.00126	0.00134	CcSEcCtD
Nitroglycerin—Mental disorder—Estradiol—osteoporosis	0.00125	0.00133	CcSEcCtD
Nitroglycerin—Dizziness—Alendronate—osteoporosis	0.00125	0.00133	CcSEcCtD
Nitroglycerin—Shock—Conjugated Estrogens—osteoporosis	0.00125	0.00133	CcSEcCtD
Nitroglycerin—Gastrointestinal disorder—Pamidronate—osteoporosis	0.00124	0.00133	CcSEcCtD
Nitroglycerin—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.00124	0.00133	CcSEcCtD
Nitroglycerin—Erythema—Estradiol—osteoporosis	0.00124	0.00133	CcSEcCtD
Nitroglycerin—Gastrointestinal pain—Risedronate—osteoporosis	0.00124	0.00132	CcSEcCtD
Nitroglycerin—Tachycardia—Conjugated Estrogens—osteoporosis	0.00124	0.00132	CcSEcCtD
Nitroglycerin—Urticaria—Ethinyl Estradiol—osteoporosis	0.00123	0.00132	CcSEcCtD
Nitroglycerin—Skin disorder—Conjugated Estrogens—osteoporosis	0.00123	0.00131	CcSEcCtD
Nitroglycerin—Hypotension—Zoledronate—osteoporosis	0.00123	0.00131	CcSEcCtD
Nitroglycerin—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.00123	0.00131	CcSEcCtD
Nitroglycerin—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.00123	0.00131	CcSEcCtD
Nitroglycerin—Dizziness—Raloxifene—osteoporosis	0.00123	0.00131	CcSEcCtD
Nitroglycerin—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.00122	0.00131	CcSEcCtD
Nitroglycerin—Vomiting—Estropipate—osteoporosis	0.00122	0.0013	CcSEcCtD
Nitroglycerin—Dizziness—Ibandronate—osteoporosis	0.00122	0.0013	CcSEcCtD
Nitroglycerin—Rash—Estropipate—osteoporosis	0.00121	0.00129	CcSEcCtD
Nitroglycerin—Dermatitis—Estropipate—osteoporosis	0.00121	0.00129	CcSEcCtD
Nitroglycerin—Urticaria—Risedronate—osteoporosis	0.0012	0.00128	CcSEcCtD
Nitroglycerin—Headache—Estropipate—osteoporosis	0.0012	0.00128	CcSEcCtD
Nitroglycerin—Vomiting—Alendronate—osteoporosis	0.0012	0.00128	CcSEcCtD
Nitroglycerin—Abdominal pain—Risedronate—osteoporosis	0.0012	0.00128	CcSEcCtD
Nitroglycerin—Body temperature increased—Risedronate—osteoporosis	0.0012	0.00128	CcSEcCtD
Nitroglycerin—Rash—Alendronate—osteoporosis	0.00119	0.00127	CcSEcCtD
Nitroglycerin—Dermatitis—Alendronate—osteoporosis	0.00119	0.00127	CcSEcCtD
Nitroglycerin—Feeling abnormal—Pamidronate—osteoporosis	0.00119	0.00127	CcSEcCtD
Nitroglycerin—Hypotension—Conjugated Estrogens—osteoporosis	0.00118	0.00126	CcSEcCtD
Nitroglycerin—Headache—Alendronate—osteoporosis	0.00118	0.00126	CcSEcCtD
Nitroglycerin—Paraesthesia—Zoledronate—osteoporosis	0.00118	0.00126	CcSEcCtD
Nitroglycerin—Vomiting—Raloxifene—osteoporosis	0.00118	0.00126	CcSEcCtD
Nitroglycerin—Gastrointestinal pain—Pamidronate—osteoporosis	0.00118	0.00126	CcSEcCtD
Nitroglycerin—Dyspnoea—Zoledronate—osteoporosis	0.00117	0.00125	CcSEcCtD
Nitroglycerin—Rash—Raloxifene—osteoporosis	0.00117	0.00125	CcSEcCtD
Nitroglycerin—GUCY1A3—Hemostasis—PLEK—osteoporosis	0.00117	0.0184	CbGpPWpGaD
Nitroglycerin—GUCY1A3—Hemostasis—ANXA2—osteoporosis	0.00117	0.0184	CbGpPWpGaD
Nitroglycerin—Dermatitis—Raloxifene—osteoporosis	0.00117	0.00125	CcSEcCtD
Nitroglycerin—Somnolence—Zoledronate—osteoporosis	0.00117	0.00125	CcSEcCtD
Nitroglycerin—Vomiting—Ibandronate—osteoporosis	0.00117	0.00125	CcSEcCtD
Nitroglycerin—Headache—Raloxifene—osteoporosis	0.00116	0.00124	CcSEcCtD
Nitroglycerin—Rash—Ibandronate—osteoporosis	0.00116	0.00124	CcSEcCtD
Nitroglycerin—Dermatitis—Ibandronate—osteoporosis	0.00116	0.00124	CcSEcCtD
Nitroglycerin—Headache—Ibandronate—osteoporosis	0.00115	0.00123	CcSEcCtD
Nitroglycerin—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.00114	0.00122	CcSEcCtD
Nitroglycerin—Vomiting—Calcitriol—osteoporosis	0.00114	0.00122	CcSEcCtD
Nitroglycerin—Agitation—Estradiol—osteoporosis	0.00114	0.00122	CcSEcCtD
Nitroglycerin—Nausea—Estropipate—osteoporosis	0.00114	0.00122	CcSEcCtD
Nitroglycerin—Body temperature increased—Pamidronate—osteoporosis	0.00114	0.00122	CcSEcCtD
Nitroglycerin—Abdominal pain—Pamidronate—osteoporosis	0.00114	0.00122	CcSEcCtD
Nitroglycerin—Paraesthesia—Conjugated Estrogens—osteoporosis	0.00114	0.00121	CcSEcCtD
Nitroglycerin—Gastrointestinal disorder—Zoledronate—osteoporosis	0.00114	0.00121	CcSEcCtD
Nitroglycerin—Angioedema—Estradiol—osteoporosis	0.00113	0.00121	CcSEcCtD
Nitroglycerin—Rash—Calcitriol—osteoporosis	0.00113	0.00121	CcSEcCtD
Nitroglycerin—Dermatitis—Calcitriol—osteoporosis	0.00113	0.00121	CcSEcCtD
Nitroglycerin—GUCY1B3—Hemostasis—TLN1—osteoporosis	0.00113	0.0178	CbGpPWpGaD
Nitroglycerin—GUCY1A2—Hemostasis—TLN1—osteoporosis	0.00113	0.0178	CbGpPWpGaD
Nitroglycerin—GUCY1A3—Myometrial Relaxation and Contraction Pathways—ADCY5—osteoporosis	0.00113	0.0178	CbGpPWpGaD
Nitroglycerin—Dyspnoea—Conjugated Estrogens—osteoporosis	0.00113	0.00121	CcSEcCtD
Nitroglycerin—Headache—Calcitriol—osteoporosis	0.00113	0.0012	CcSEcCtD
Nitroglycerin—Somnolence—Conjugated Estrogens—osteoporosis	0.00113	0.0012	CcSEcCtD
Nitroglycerin—Nausea—Alendronate—osteoporosis	0.00112	0.0012	CcSEcCtD
Nitroglycerin—GUCY1A2—Hemostasis—VCL—osteoporosis	0.00112	0.0176	CbGpPWpGaD
Nitroglycerin—GUCY1B3—Hemostasis—VCL—osteoporosis	0.00112	0.0176	CbGpPWpGaD
Nitroglycerin—Hypersensitivity—Risedronate—osteoporosis	0.00112	0.00119	CcSEcCtD
Nitroglycerin—Vertigo—Estradiol—osteoporosis	0.00112	0.00119	CcSEcCtD
Nitroglycerin—Asthenia—Ethinyl Estradiol—osteoporosis	0.00111	0.00119	CcSEcCtD
Nitroglycerin—Syncope—Estradiol—osteoporosis	0.00111	0.00119	CcSEcCtD
Nitroglycerin—Nausea—Raloxifene—osteoporosis	0.0011	0.00118	CcSEcCtD
Nitroglycerin—Pruritus—Ethinyl Estradiol—osteoporosis	0.0011	0.00117	CcSEcCtD
Nitroglycerin—Palpitations—Estradiol—osteoporosis	0.0011	0.00117	CcSEcCtD
Nitroglycerin—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.00109	0.00117	CcSEcCtD
Nitroglycerin—Nausea—Ibandronate—osteoporosis	0.00109	0.00117	CcSEcCtD
Nitroglycerin—Loss of consciousness—Estradiol—osteoporosis	0.00109	0.00117	CcSEcCtD
Nitroglycerin—Asthenia—Risedronate—osteoporosis	0.00109	0.00116	CcSEcCtD
Nitroglycerin—Feeling abnormal—Zoledronate—osteoporosis	0.00108	0.00116	CcSEcCtD
Nitroglycerin—Gastrointestinal pain—Zoledronate—osteoporosis	0.00108	0.00115	CcSEcCtD
Nitroglycerin—Pruritus—Risedronate—osteoporosis	0.00107	0.00114	CcSEcCtD
Nitroglycerin—Nausea—Calcitriol—osteoporosis	0.00107	0.00114	CcSEcCtD
Nitroglycerin—Hypersensitivity—Pamidronate—osteoporosis	0.00106	0.00113	CcSEcCtD
Nitroglycerin—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	0.00105	0.00112	CcSEcCtD
Nitroglycerin—Urticaria—Zoledronate—osteoporosis	0.00104	0.00112	CcSEcCtD
Nitroglycerin—Abdominal pain—Zoledronate—osteoporosis	0.00104	0.00111	CcSEcCtD
Nitroglycerin—Body temperature increased—Zoledronate—osteoporosis	0.00104	0.00111	CcSEcCtD
Nitroglycerin—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.00104	0.00111	CcSEcCtD
Nitroglycerin—Asthenia—Pamidronate—osteoporosis	0.00103	0.0011	CcSEcCtD
Nitroglycerin—Dizziness—Ethinyl Estradiol—osteoporosis	0.00103	0.0011	CcSEcCtD
Nitroglycerin—Confusional state—Estradiol—osteoporosis	0.00102	0.00109	CcSEcCtD
Nitroglycerin—Pruritus—Pamidronate—osteoporosis	0.00102	0.00109	CcSEcCtD
Nitroglycerin—Anaphylactic shock—Estradiol—osteoporosis	0.00101	0.00108	CcSEcCtD
Nitroglycerin—GUCY1A3—Hemostasis—TLN1—osteoporosis	0.00101	0.0159	CbGpPWpGaD
Nitroglycerin—Infection—Estradiol—osteoporosis	0.00101	0.00107	CcSEcCtD
Nitroglycerin—Urticaria—Conjugated Estrogens—osteoporosis	0.00101	0.00107	CcSEcCtD
Nitroglycerin—Dizziness—Risedronate—osteoporosis	0.001	0.00107	CcSEcCtD
Nitroglycerin—Abdominal pain—Conjugated Estrogens—osteoporosis	0.001	0.00107	CcSEcCtD
Nitroglycerin—Body temperature increased—Conjugated Estrogens—osteoporosis	0.001	0.00107	CcSEcCtD
Nitroglycerin—Shock—Estradiol—osteoporosis	0.000997	0.00106	CcSEcCtD
Nitroglycerin—GUCY1A3—Hemostasis—VCL—osteoporosis	0.000995	0.0157	CbGpPWpGaD
Nitroglycerin—Nervous system disorder—Estradiol—osteoporosis	0.000994	0.00106	CcSEcCtD
Nitroglycerin—Tachycardia—Estradiol—osteoporosis	0.000989	0.00106	CcSEcCtD
Nitroglycerin—Vomiting—Ethinyl Estradiol—osteoporosis	0.000988	0.00105	CcSEcCtD
Nitroglycerin—Skin disorder—Estradiol—osteoporosis	0.000984	0.00105	CcSEcCtD
Nitroglycerin—Hyperhidrosis—Estradiol—osteoporosis	0.00098	0.00105	CcSEcCtD
Nitroglycerin—Rash—Ethinyl Estradiol—osteoporosis	0.000979	0.00105	CcSEcCtD
Nitroglycerin—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000978	0.00104	CcSEcCtD
Nitroglycerin—Headache—Ethinyl Estradiol—osteoporosis	0.000973	0.00104	CcSEcCtD
Nitroglycerin—Hypersensitivity—Zoledronate—osteoporosis	0.000969	0.00103	CcSEcCtD
Nitroglycerin—Vomiting—Risedronate—osteoporosis	0.000963	0.00103	CcSEcCtD
Nitroglycerin—Rash—Risedronate—osteoporosis	0.000955	0.00102	CcSEcCtD
Nitroglycerin—Dermatitis—Risedronate—osteoporosis	0.000954	0.00102	CcSEcCtD
Nitroglycerin—Dizziness—Pamidronate—osteoporosis	0.000952	0.00102	CcSEcCtD
Nitroglycerin—Headache—Risedronate—osteoporosis	0.000949	0.00101	CcSEcCtD
Nitroglycerin—Asthenia—Zoledronate—osteoporosis	0.000943	0.00101	CcSEcCtD
Nitroglycerin—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.000933	0.000996	CcSEcCtD
Nitroglycerin—GUCY1B3—Hemostasis—RAP1A—osteoporosis	0.000933	0.0147	CbGpPWpGaD
Nitroglycerin—GUCY1A2—Hemostasis—RAP1A—osteoporosis	0.000933	0.0147	CbGpPWpGaD
Nitroglycerin—Pruritus—Zoledronate—osteoporosis	0.00093	0.000993	CcSEcCtD
Nitroglycerin—ALDH2—Phase 1 - Functionalization of compounds—POMC—osteoporosis	0.000928	0.0146	CbGpPWpGaD
Nitroglycerin—Nausea—Ethinyl Estradiol—osteoporosis	0.000923	0.000985	CcSEcCtD
Nitroglycerin—Vomiting—Pamidronate—osteoporosis	0.000915	0.000977	CcSEcCtD
Nitroglycerin—Paraesthesia—Estradiol—osteoporosis	0.00091	0.000972	CcSEcCtD
Nitroglycerin—Asthenia—Conjugated Estrogens—osteoporosis	0.000908	0.00097	CcSEcCtD
Nitroglycerin—Rash—Pamidronate—osteoporosis	0.000908	0.000969	CcSEcCtD
Nitroglycerin—Dermatitis—Pamidronate—osteoporosis	0.000907	0.000968	CcSEcCtD
Nitroglycerin—Dyspnoea—Estradiol—osteoporosis	0.000903	0.000965	CcSEcCtD
Nitroglycerin—Headache—Pamidronate—osteoporosis	0.000902	0.000963	CcSEcCtD
Nitroglycerin—Somnolence—Estradiol—osteoporosis	0.000901	0.000962	CcSEcCtD
Nitroglycerin—Nausea—Risedronate—osteoporosis	0.000899	0.00096	CcSEcCtD
Nitroglycerin—Pruritus—Conjugated Estrogens—osteoporosis	0.000896	0.000956	CcSEcCtD
Nitroglycerin—Gastrointestinal disorder—Estradiol—osteoporosis	0.000875	0.000934	CcSEcCtD
Nitroglycerin—Dizziness—Zoledronate—osteoporosis	0.00087	0.000928	CcSEcCtD
Nitroglycerin—Nausea—Pamidronate—osteoporosis	0.000855	0.000913	CcSEcCtD
Nitroglycerin—GUCY1A2—Hemostasis—FGA—osteoporosis	0.000846	0.0133	CbGpPWpGaD
Nitroglycerin—GUCY1B3—Hemostasis—FGA—osteoporosis	0.000846	0.0133	CbGpPWpGaD
Nitroglycerin—Dizziness—Conjugated Estrogens—osteoporosis	0.000837	0.000894	CcSEcCtD
Nitroglycerin—Vomiting—Zoledronate—osteoporosis	0.000836	0.000893	CcSEcCtD
Nitroglycerin—Feeling abnormal—Estradiol—osteoporosis	0.000835	0.000892	CcSEcCtD
Nitroglycerin—GUCY1A3—Hemostasis—RAP1A—osteoporosis	0.000831	0.0131	CbGpPWpGaD
Nitroglycerin—Rash—Zoledronate—osteoporosis	0.000829	0.000885	CcSEcCtD
Nitroglycerin—Gastrointestinal pain—Estradiol—osteoporosis	0.000829	0.000885	CcSEcCtD
Nitroglycerin—Dermatitis—Zoledronate—osteoporosis	0.000828	0.000884	CcSEcCtD
Nitroglycerin—Headache—Zoledronate—osteoporosis	0.000824	0.00088	CcSEcCtD
Nitroglycerin—ALDH2—Biological oxidations—CYP19A1—osteoporosis	0.000821	0.0129	CbGpPWpGaD
Nitroglycerin—Vomiting—Conjugated Estrogens—osteoporosis	0.000805	0.00086	CcSEcCtD
Nitroglycerin—Urticaria—Estradiol—osteoporosis	0.000805	0.00086	CcSEcCtD
Nitroglycerin—Body temperature increased—Estradiol—osteoporosis	0.000801	0.000855	CcSEcCtD
Nitroglycerin—Abdominal pain—Estradiol—osteoporosis	0.000801	0.000855	CcSEcCtD
Nitroglycerin—Rash—Conjugated Estrogens—osteoporosis	0.000798	0.000852	CcSEcCtD
Nitroglycerin—Dermatitis—Conjugated Estrogens—osteoporosis	0.000798	0.000852	CcSEcCtD
Nitroglycerin—Headache—Conjugated Estrogens—osteoporosis	0.000793	0.000847	CcSEcCtD
Nitroglycerin—Nausea—Zoledronate—osteoporosis	0.000781	0.000834	CcSEcCtD
Nitroglycerin—GUCY1B3—Hemostasis—FGB—osteoporosis	0.00077	0.0121	CbGpPWpGaD
Nitroglycerin—GUCY1A2—Hemostasis—FGB—osteoporosis	0.00077	0.0121	CbGpPWpGaD
Nitroglycerin—GUCY1A3—Hemostasis—FGA—osteoporosis	0.000754	0.0119	CbGpPWpGaD
Nitroglycerin—Nausea—Conjugated Estrogens—osteoporosis	0.000752	0.000803	CcSEcCtD
Nitroglycerin—Hypersensitivity—Estradiol—osteoporosis	0.000747	0.000797	CcSEcCtD
Nitroglycerin—Asthenia—Estradiol—osteoporosis	0.000727	0.000776	CcSEcCtD
Nitroglycerin—Pruritus—Estradiol—osteoporosis	0.000717	0.000765	CcSEcCtD
Nitroglycerin—GUCY1A3—Hemostasis—FGB—osteoporosis	0.000686	0.0108	CbGpPWpGaD
Nitroglycerin—Dizziness—Estradiol—osteoporosis	0.00067	0.000715	CcSEcCtD
Nitroglycerin—Vomiting—Estradiol—osteoporosis	0.000644	0.000688	CcSEcCtD
Nitroglycerin—Rash—Estradiol—osteoporosis	0.000639	0.000682	CcSEcCtD
Nitroglycerin—Dermatitis—Estradiol—osteoporosis	0.000638	0.000682	CcSEcCtD
Nitroglycerin—Headache—Estradiol—osteoporosis	0.000635	0.000678	CcSEcCtD
Nitroglycerin—GUCY1A3—Myometrial Relaxation and Contraction Pathways—IL1B—osteoporosis	0.000617	0.00973	CbGpPWpGaD
Nitroglycerin—Nausea—Estradiol—osteoporosis	0.000602	0.000643	CcSEcCtD
Nitroglycerin—ALDH2—Transmission across Chemical Synapses—ADCY5—osteoporosis	0.000594	0.00937	CbGpPWpGaD
Nitroglycerin—ALDH2—Biological oxidations—POMC—osteoporosis	0.000493	0.00777	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—FDPS—osteoporosis	0.000465	0.00733	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—PKM—osteoporosis	0.000465	0.00733	CbGpPWpGaD
Nitroglycerin—ALDH2—Neuronal System—ADCY5—osteoporosis	0.000455	0.00718	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—PGLS—osteoporosis	0.000441	0.00695	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—GPD2—osteoporosis	0.000441	0.00695	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—PNP—osteoporosis	0.000403	0.00636	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—ATIC—osteoporosis	0.000403	0.00636	CbGpPWpGaD
Nitroglycerin—GUCY1A3—Myometrial Relaxation and Contraction Pathways—IL6—osteoporosis	0.000361	0.0057	CbGpPWpGaD
Nitroglycerin—GUCY1A2—Hemostasis—IGF1—osteoporosis	0.000348	0.00549	CbGpPWpGaD
Nitroglycerin—GUCY1B3—Hemostasis—IGF1—osteoporosis	0.000348	0.00549	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—CA2—osteoporosis	0.000343	0.0054	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—OXCT1—osteoporosis	0.000343	0.0054	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—MGLL—osteoporosis	0.000334	0.00527	CbGpPWpGaD
Nitroglycerin—GUCY1A3—Hemostasis—IGF1—osteoporosis	0.000311	0.00489	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—IDH2—osteoporosis	0.000284	0.00448	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—CYP27A1—osteoporosis	0.000267	0.00421	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—ACP5—osteoporosis	0.00026	0.0041	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—TPI1—osteoporosis	0.000242	0.00381	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—P4HB—osteoporosis	0.000227	0.00358	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—GAPDH—osteoporosis	0.000223	0.00351	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—RAP1A—osteoporosis	0.000217	0.00342	CbGpPWpGaD
Nitroglycerin—GUCY1A2—Hemostasis—TGFB1—osteoporosis	0.000209	0.00329	CbGpPWpGaD
Nitroglycerin—GUCY1B3—Hemostasis—TGFB1—osteoporosis	0.000209	0.00329	CbGpPWpGaD
Nitroglycerin—GUCY1A3—Hemostasis—TGFB1—osteoporosis	0.000186	0.00293	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—ENO1—osteoporosis	0.000176	0.00277	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—PSMA2—osteoporosis	0.000173	0.00273	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—PSMA5—osteoporosis	0.000173	0.00273	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—CYP19A1—osteoporosis	0.00014	0.00221	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—ADCY5—osteoporosis	0.000115	0.00181	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—GPX1—osteoporosis	0.000114	0.0018	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—MTHFR—osteoporosis	0.000105	0.00166	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—POMC—osteoporosis	8.43e-05	0.00133	CbGpPWpGaD
